Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Asako Hiraoka is active.

Publication


Featured researches published by Asako Hiraoka.


Transfusion | 2004

Significance of human neutrophil antigen-2a (NB1) expression and neutrophil number in pregnancy

Kikuyo Taniguchi; Hideaki Nagata; Takafumi Katsuki; Chiyoko Nakashima; Rie Onodera; Asako Hiraoka; Noboru Takata; Masao Kobayashi; Masayuki Kambe

BACKGROUND: Expression of human neutrophil antigen‐2a (HNA‐2a) is greater in women than in men. The size of the HNA‐2a‐positive neutrophil population increases with pregnancy.


Transfusion | 2001

A possible role for maternal HLA antibody in a case of alloimmune neonatal neutropenia

Rokuro Hagimoto; Kenichi Koike; Kazuo Sakashita; Takefumi Ishida; Yozo Nakazawa; Yumi Kurokawa; Takehiko Kamijo; Satoshi Saito; Asako Hiraoka; Masao Kobayashi; Atsushi Komiyama

BACKGROUND: Alloimmune neonatal neutropenia (ANN) is caused by a reaction of maternal alloantibodies with paternally inherited antigens on the fetal neutrophils. While human neutrophil antigens (HNA) antibodies are found in half of ANN cases, specific antibodies have not been defined in the remaining cases.


Journal of Pediatric Hematology Oncology | 2003

Efficacy of prophylactic use of Trimethoprim-Sulfamethoxazole in autoimmune neutropenia in infancy

Masao Kobayashi; Takashi Sato; Hiroshi Kawaguchi; Kazuhiro Nakamura; Hirotaka Kihara; Asako Hiraoka; Misae Tanihiro; Kikuyo Taniguchi; Noboru Takata; Kazuhiro Ueda

Purpose Most children with autoimmune neutropenia (AIN) have a benign clinical course because of the spontaneous resolution of neutropenia. The authors observed the clinical course of AIN in infancy accompanied by the prophylactic use of trimethoprim–sulfamethoxazole (TMP-SMX) during neutropenia. Patients and Methods Eight infants with AIN were followed by serial tests for antineutrophil antibodies and management of infectious complications. Results The spontaneous disappearance of antineutrophil antibodies that preceded the normalization of the neutrophil count was found in all patients. Until the resolution of neutropenia, TMP-SMX was administered in five patients, resulting in a reduction in the incidence of infection with no adverse effects. Conclusions These observations demonstrate the possibility of the safety and usefulness of TMP-SMX treatment in patients with AIN.


British Journal of Haematology | 2007

Monitoring neutrophil engraftment in allogeneic stem cell transplantation by flow cytometric analysis of neutrophil‐specific antigens NA1 and NA2

Takeshi Inukai; Kanako Uno; Kikuyo Taniguchi; Kumiko Goi; Toru Tezuka; Atsushi Nemoto; Kazuya Takahashi; Hiroki Sato; Koshi Akahane; Kinuko Hirose; Hiroko Honna; Keiko Kagami; Asako Hiraoka; Misae Tanihiro; Shinpei Nakazawa; Kanji Sugita

Neutrophil‐specific antigen (NA) expression on neutrophils was analysed in 18 Japanese children before and after allogeneic stem cell transplantation (allo‐SCT) with myeloablative regimen. Donor–recipient NA‐incompatibility was present in one of eight NA1/NA2 heterozygous patients and eight of 10 NA1/NA1 or NA2/NA2 homozygous patients. After allo‐SCTs from NA‐incompatible donors, a neutrophil recipient‐to‐donor conversion was confirmed in all cases. Conversion to donor NA type was complete before the absolute neutrophil count reached 0·1 × 109/l. These observations indicate that flow cytometric analysis of NA antigens is a simple and useful method for monitoring neutrophil engraftment in NA‐incompatible allo‐SCT.


Pediatrics International | 2009

Successful bone marrow transplantation in chronic granulomatous disease

Mizuka Miki; Atsushi Ono; Ayumi Awaya; Shin-ichiro Miyagawa; Rie Onodera; Emi Kurita; Asako Hiraoka; Fumio Hidaka; Tomoyuki Mizukami; Hiroyuki Nunoi; Masao Kobayashi

WC. Urinary tract infections due to Candida albicans. Rev. Infect. Dis. 1982; 4: 1107–18. 3 Wimalendra M, Reece A, Nicholl RM. Renal fungal ball. Arch. Dis. Child. Fetal Neonatal Ed. 2004; 89: F376. 4 Blanc PL, Berne D, Annweiler M, Marc JM, Béal A, Bedock B. [Candidal bezoar of the urinary tract during Candida albicans septicemia]. Nephrologie 1993; 14: 19–22. 5 Jantausch B, Kher K Urinary tract infections. In: Kher K, Schnaper HW, Makker SP (eds). Clinical Pediatric Nephrology, 2nd edn. Informa UK, Abingdon, Oxon, 2007; 553–74. 6 Krishnamurthy R, Aparajitha C, Abraham G, Shroff S, Sekar U, Kuruvilla S. Renal aspergillosis giving rise to obstructive uropathy and recurrent anuric renal failure. Geriatr. Nephrol. Urol. 1998; 8: 137–9. 7 Baetz-Greenwalt B, Debaz B, Kumar ML. Bladder fungus ball: A reversible cause of neonatal obstructive uropathy. Pediatrics 1988; 81: 826–9. 8 Sánchez Sanchís M, Pastor Lence J, San Juan de Laorden C, Llopis Guixot B, Tarin Planes M, Carrascosa Lloret V. [Candidiasis of the upper urinary tract. Report of a case]. Arch. Esp. Urol. 1996; 49: 66–8. 9 Alkalay AL, Srugo I, Blifeld C, Komaiko MS, Pomerance JJ. Noninvasive medical management of fungus ball uropathy in a premature infant. Am. J. Perinatol. 1991; 8: 330–2. 10 Hershman-Sarafov M, Tubi O, Srugo I, Bader D. [Fungus-ball in a preterm infant successfully treated with fluconazole]. Harefuah 1998; 134: 28–30. 11 Burguet A, Menget A, Fromentin C, Aubert D, Costaz R, Lemouel A. [Anuria in an infant caused by an intrapyelic mycelial bezoar in a solitary kidney]. Arch. Fr. Pediatr. 1988; 45: 341–2. 12 Alvarez Kindelán J, Alameda Aragonéses V, Regueiro López JC et al. [Management of obstructive renal candidiasis. Report of a clinical case]. Actas Urol. Esp. 1997; 21: 290–92. 13 Levin DL, Zimmerman AL, Ferder LF, Shapiro WB, Wax SH, Porush JG. Acute renal failure secondary to ureteral fungus ball obstruction in a patient with reversible deficient cell-mediated immunity. Clin. Nephrol. 1975; 4: 202–10. 14 Navarro Sebastián J, Hidalgo Togores L, Cárcamo Valor P et al. [Renal candidiasis: Percutaneous endoscopic treatment of the pyeloureteral fungus-ball]. Arch. Esp. Urol. 1990; 43: 543–9. 15 Martínez Bengoechea J, Allepuz Losa C, Gil Sanz MJ, Minguez Pemán J, Rioja Sanz LA. [Systemic candidiasis and ureteral fungus ball. Ketoconazole and irrigating solutions in the management of urinary candidiasis]. Actas Urol. Esp. 1990; 14: 314–18. 16 Prat O, Schurr D, Pomeranz A, Farkas A, Drukker A. Renal candidiasis in infancy: A case with fungus ball obstruction. Int. J. Pediatr. Nephrol. 1984; 5: 223–6. 17 Lo Cascio M, Podestà E, Fatta G, De Angelis M, Toma P. [A rare cause of urologic emergency in childhood: Obstruction of the urinary tract caused by Candida]. Pediatr. Med. Chir. 1987; 9: 239–42. 18 Burgués Gasión JP, Alapont Alacreu JM, Oliver Amorós F, Benedicto Redón A, Boronat Tormo F, Jiménez Cruz JF. [Pyeloureteral fungus ball in patients with urinary lithiasis. Treatment with ureterorenoscopy]. Actas Urol. Esp. 2003; 27: 60–64. 19 Montalvo JA, Montaner A, Torino JR, Ribó JM, Morales L. [Obstructive candidiasis: A process with surgical solution]. Cir. Pediatr. 1994; 7: 204–6. 20 Fisher J, Mayhall G, Duma R, Shadomy S, Shadomy J, Watlington C. Fungus balls of the urinary tract. South. Med. J. 1979; 72: 1281–4. 21 Abramowitz J, Fowler JE, Talluri K et al. Percutaneous identification and removal of fungus ball from renal pelvis. J. Urol. 1986; 135: 1232–3. 22 Menéndez López V, Elia López M, Llorens Martínez FJ, Galán Llopis JA, de Nova Sánchez E, García López F. [Treatment of pelvis fungus ball with ureteral catheterization, fluconazole, and urine alkalinization]. Actas Urol. Esp. 1999; 23: 167–70. 23 Benjamin DK Jr, Fisher RG, McKinney RE Jr, Benjamin DK. Candidal mycetoma in the neonatal kidney. Pediatrics 1999; 104: 1126–9. 24 Biyikli NK, Tugtepe H, Akpinar I, Alpay H, Ozek E. The longest use of liposomal amphotericin B and 5-fluorocytosine in neonatal renal candidiasis. Pediatr. Nephrol. 2004; 19: 801–4.


Pediatrics International | 2009

Dizygotic twins with neonatal alloimmune neutropenia associated with maternal anti-human neutrophil antigen-1b antibody

Masamune Higashigawa; Hisashi Nishimori; Yoshihiro Komada; Rie Onodera; Asako Hiraoka; Masao Kobayashi

organs, including cataracts, heart and lung disorders, gastrointestinal problems, and central nervous dysfunction. And the endocrinological abnormalities, hypogonadism and hyperinsulinemia, are well described. Additionally, both abnormal glucocorticoid metabolism and poor adrenocortical reactivity to adrenocorticotropic hormone (ACTH) have been reported as adrenocortical dysfunctions. DM1-associated hyperkalemia has been reported in only a few cases of adult MD. Misra et al. reported three MD patients with hyperkalemia suggestive of hyperreninemic hypoaldosteronism. In those patients replacement therapy with a mineral corticoid (fludrocortisone) was ineffective. Although the mechanisms of adrenal hyporesponsiveness and resistance to exogenous mineral corticoid are unclear, abnormal DMPK activity may influence the expression of cytokines, ACTH, and atrial natriuretic hormone, and may be related to adrenocortical disorders. Abnormalities of skeletal muscle ionic channels and pumps during MD are well known. Especially with regard to potassium control, increases in the apamin-sensitive small-conductance Ca2+-activated K channel (SK3) and decreases in the Na+-K+ pump have been discovered. These complexes are thought to influence the stability of the resting membrane potential and to assist in depolarization. Furthermore, the Na+-K+ pump on red blood cell membranes is thought to be dysfunctional in MD. Thus, the abnormalities of these channels and pumps with regard to potassium could potentially induce hyperkalemia. In the current case, the same mechanism was thought to play an important role in the occurrence of hyperkalemia. Furthermore, hyperkalemia was improved, but not completely, at discharge. We considered the possibility that the function of channels or pumps had improved with the passing of time, but not completely. Although hyperkalemia is not common in CMD, and the mechanism of this unusual electrolyte abnormality has not been clearly defined, critical symptomatic hyperkalemia with atrial flutter and atrial fibrillation has been reported during adult MD. Based on this experience, hyperkalemia may also complicate CMD.


Blood | 2002

Significance of the detection of antineutrophil antibodies in children with chronic neutropenia

Masao Kobayashi; Kazuhiro Nakamura; Hiroshi Kawaguchi; Takashi Sato; Hirotaka Kihara; Asako Hiraoka; Misae Tanihiro; Kikuyo Taniguchi; Noboru Takata; Kazuhiro Ueda


Transfusion | 2002

Human neutrophil antigen-2a expression on neutrophils from healthy adults in western Japan

Kikuyo Taniguchi; Masao Kobayashi; Hironori Harada; Asako Hiraoka; Misae Tanihiro; Noboru Takata; Akiro Kimura


Blood | 2006

Successful Bone Marrow Transplantation with an Intensively Immunosuppressive Conditioning with Low Toxicity for High-Risk Chronic Granulomatous Disease Patients.

Mizuka Miki; Teruyuki Kajiume; Kazuhiro Nakamura; Hiroshi Kawaguchi; Takashi Sato; Emi Kurita; Rie Onodera; Asako Hiraoka; Tomoyuki Mizukami; Hiroyuki Nunoi; Masao Kobayashi


Journal of the Japan Society of Blood Transfusion | 1999

Development of A Novel Monoclonal Antibody, TAG2, to The Neutrophil-Specific Antigen NA2.

Kikuyo Taniguchi; Masao Kobayashi; Misae Tanihiro; Asako Hiraoka; Kosuke Okada; Noboru Takata; Hirotaka Kihara; Kazuhiro Ueda

Collaboration


Dive into the Asako Hiraoka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge